Aliases & Classifications for Iridocyclitis

Summaries for Iridocyclitis

MalaCards based summary : Iridocyclitis, also known as primary iridocyclitis, is related to fuchs' heterochromic uveitis and anterior uveitis. An important gene associated with Iridocyclitis is DEK (DEK Proto-Oncogene), and among its related pathways/superpathways are Interferon gamma signaling and Immune response Role of DAP12 receptors in NK cells. The drugs Adalimumab and Ganciclovir have been mentioned in the context of this disorder. Affiliated tissues include eye, retina and endothelial, and related phenotypes are Increased shRNA abundance (Z-score > 2) and Increased shRNA abundance (Z-score > 2)

Wikipedia : 77 Uveitis is the inflammation of the uvea, the pigmented layer that lies between the inner retina and the... more...

Related Diseases for Iridocyclitis

Diseases related to Iridocyclitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 130)
# Related Disease Score Top Affiliating Genes
1 fuchs' heterochromic uveitis 33.8 CYP11B1 MRAP
2 anterior uveitis 32.7 HLA-A HLA-B
3 juvenile rheumatoid arthritis 30.3 DEK HLA-DPB1
4 vogt-koyanagi-harada disease 30.2 HLA-A HLA-B
5 iritis 30.1 HLA-B MRAP
6 pars planitis 30.1 HLA-A HLA-B
7 cytomegalovirus retinitis 29.7 HLA-A HLA-B
8 rubella 29.7 HLA-A HLA-B HLA-DPB1
9 herpes zoster 29.6 HLA-A HLA-B
10 spondyloarthropathy 1 29.6 HLA-B MRAP
11 glaucomatocyclitic crisis 29.0 CYP11B1 HLA-A HLA-B HLA-DPB1 MRAP
12 lens-induced iridocyclitis 12.3
13 gonococcal iridocyclitis 12.1
14 infectious anterior uveitis 11.7
15 phacoanaphylactic uveitis 11.6
16 retinal vasculitis 11.2
17 uveitis 10.8
18 idiopathic anterior uveitis 10.6
19 arthritis 10.6
20 rheumatoid arthritis 10.5
21 cataract 10.4
22 herpes simplex 10.2
23 diffuse infiltrative lymphocytosis syndrome 10.2 MRAP TNFRSF10B
24 chikungunya 10.1
25 hypopyon 10.1
26 toxoplasmosis 10.1
27 phenytoin or carbamazepine toxicity 10.1 HLA-A HLA-B
28 postherpetic neuralgia 10.1 HLA-A HLA-B
29 atrial tachyarrhythmia with short pr interval 10.1 HLA-A HLA-B
30 htlv-1 associated myelopathy/tropical spastic paraparesis 10.1 HLA-A HLA-B
31 pityriasis rosea 10.1 HLA-A HLA-B
32 chronic pyelonephritis 10.1 HLA-A HLA-B
33 uveal disease 10.0 HLA-B MRAP
34 human herpesvirus 8 10.0 HLA-A HLA-B
35 nontuberculous mycobacterial lung disease 10.0 HLA-A HLA-B
36 idiopathic bronchiectasis 10.0 HLA-A HLA-B
37 histoplasmosis 10.0 HLA-A HLA-B
38 retinitis 10.0
39 syphilis 10.0
40 conjunctivitis 10.0
41 psoriasis 10.0
42 ocular toxoplasmosis 10.0
43 alveolar echinococcosis 10.0 HLA-A HLA-B
44 hematopoietic stem cell transplantation 10.0 HLA-A HLA-B
45 separation anxiety disorder 10.0 HLA-A HLA-B
46 stevens-johnson syndrome/toxic epidermal necrolysis 10.0 HLA-A HLA-B
47 aphthous stomatitis 10.0 HLA-A HLA-B
48 spondyloarthropathy 10.0 HLA-A HLA-B
49 paraneoplastic pemphigus 10.0 HLA-A HLA-B
50 astigmatism 9.9

Graphical network of the top 20 diseases related to Iridocyclitis:



Diseases related to Iridocyclitis

Symptoms & Phenotypes for Iridocyclitis

GenomeRNAi Phenotypes related to Iridocyclitis according to GeneCards Suite gene sharing:

27
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-103 9.58 HLA-A HLA-B
2 Increased shRNA abundance (Z-score > 2) GR00366-A-110 9.58 HLA-A HLA-B
3 Increased shRNA abundance (Z-score > 2) GR00366-A-118 9.58 HLA-A HLA-B
4 Increased shRNA abundance (Z-score > 2) GR00366-A-156 9.58 HLA-A HLA-B
5 Increased shRNA abundance (Z-score > 2) GR00366-A-178 9.58 HLA-A HLA-B
6 Increased shRNA abundance (Z-score > 2) GR00366-A-19 9.58 HLA-A HLA-B
7 Increased shRNA abundance (Z-score > 2) GR00366-A-31 9.58 HLA-A HLA-B
8 Increased shRNA abundance (Z-score > 2) GR00366-A-7 9.58 HLA-A HLA-B
9 Increased shRNA abundance (Z-score > 2) GR00366-A-74 9.58 HLA-A HLA-B

Drugs & Therapeutics for Iridocyclitis

Drugs for Iridocyclitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 119)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Adalimumab Approved Phase 4,Phase 3 331731-18-1 16219006
2
Ganciclovir Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 82410-32-0 3454
3
Prednisolone phosphate Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 302-25-0
4
Methylprednisolone hemisuccinate Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 2921-57-5
5
Acyclovir Approved Phase 4,Phase 3 59277-89-3 2022
6
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-24-8 5755
7
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 83-43-2 6741
8
leucovorin Approved Phase 4,Phase 1,Not Applicable 58-05-9 143 6006
9
Methotrexate Approved Phase 4,Not Applicable 1959-05-2, 59-05-2 126941
10
Dinoprost tromethamine Approved, Vet_approved Phase 4 38562-01-5 5282415
11
Dinoprost Approved, Investigational Phase 4 551-11-1 5283078
12
Bimatoprost Approved, Investigational Phase 4 155206-00-1 5311027
13
Difluprednate Approved Phase 4,Phase 3,Phase 2 23674-86-4 443936
14
Certolizumab pegol Approved Phase 4,Phase 3 428863-50-7
15
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 1,Not Applicable 59-30-3 6037
16
Prednisolone hemisuccinate Experimental Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 2920-86-7
17 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
18 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
19 Hormones Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
20 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
21 Antirheumatic Agents Phase 4,Phase 3,Not Applicable
22 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
23 Ganciclovir triphosphate Phase 4,Phase 2,Phase 3,Not Applicable
24 Antiviral Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
25 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
26 Immunologic Factors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
27 Immunosuppressive Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
28 Methylprednisolone Acetate Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
29 Prednisolone acetate Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
30 Antimetabolites, Antineoplastic Phase 4,Not Applicable
31 Folate Phase 4,Phase 1,Not Applicable
32 Vitamin B9 Phase 4,Phase 1,Not Applicable
33 Vitamin B Complex Phase 4,Phase 1,Not Applicable
34 Folic Acid Antagonists Phase 4,Phase 1,Not Applicable
35 Dermatologic Agents Phase 4,Phase 3,Not Applicable
36 Antimetabolites Phase 4,Not Applicable
37 Melanocyte-Stimulating Hormones Phase 4,Not Applicable
38 beta-endorphin Phase 4,Not Applicable
39 Adrenocorticotropic Hormone Phase 4,Not Applicable
40 Oxytocics Phase 4
41 Benzalkonium Compounds Phase 4,Phase 3
42 Ophthalmic Solutions Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
43 Lubricant Eye Drops Phase 4
44 Antihypertensive Agents Phase 4
45 Anti-Infective Agents, Local Phase 4,Phase 3
46 Pharmaceutical Solutions Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
47 valacyclovir Phase 4
48
Ranibizumab Approved Phase 2, Phase 3 347396-82-1 459903
49
Etanercept Approved, Investigational Phase 3,Not Applicable 185243-69-0
50
Fluprednisolone Approved Phase 3,Phase 2 53-34-9

Interventional clinical trials:

(show top 50) (show all 69)
# Name Status NCT ID Phase Drugs
1 Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients Completed NCT02764697 Phase 4 H.P. ACTHAR SUBCUTANEOUS GEL INJECTION
2 Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study) Completed NCT02059655 Phase 4 Bimatoprost;Eye drop solution
3 A Study Treating Participants With Early Axial Spondyloarthritis (axSpA) Taking an Intense Treatment Approach Versus Routine Treatment Completed NCT02897115 Phase 4
4 Topical 2% Ganciclovir Eye Drop for CMV Anterior Uveitis / Endotheliitis Recruiting NCT02943057 Phase 4 2% guttae ganciclovir
5 A Study to Assess the Effects of Certolizumab Pegol on the Reduction of Anterior Uveitis (AU) Flares in Axial Spondyloarthritis Subjects With a Documented History of AU Active, not recruiting NCT03020992 Phase 4 Certolizumab Pegol
6 Topical Corticosteroid Use in Addition to Oral Antivirals for Prevention of Recurrence of Herpes Simplex Virus (HSV) Keratitis Not yet recruiting NCT03626376 Phase 4 oral acyclovir 400 mg BID OR valacyclovir 500 mg qdaily;oral acyclovir 400 mg BID OR valacyclovir 500 mg qdaily + topical corticosteroid eye drops
7 Open Label Study of Acthar SQ Gel Injection in Patients With Active Anterior Uveitis Terminated NCT02769702 Phase 4 Acthar
8 Methotrexate in the Treatment of Axial Spondyloarthritis Withdrawn NCT00298012 Phase 4 Methotrexate
9 Herpetic Eye Disease Study (HEDS) I Unknown status NCT00000138 Phase 3 Prednisolone Phosphate;Acyclovir
10 Double-dose Ranibizumab for Polypoidal Choroidal Vasculopathy Unknown status NCT02769169 Phase 2, Phase 3 Lucentis® (Raibizumab) double-dose;Lucentis® (Raibizumab) regular-dose
11 Safety and Efficacy of Difluprednate 0.05% for the Treatment of Anterior Uveitis Completed NCT01201798 Phase 3 Difluprednate 0.05% ophthalmic emulsion;Prednisolone acetate 1.0% ophthalmic suspension
12 A Multi-center Study to Assess the Efficacy and Safety of LX211 in Active Non-infectious Anterior Uveitis Completed NCT00404885 Phase 3 Placebo;LX211;LX211;LX211
13 Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Non-Infectious Anterior Uveitis Completed NCT02517619 Phase 3 Dexamethasone Phosphate Ophthalmic Solution;Prednisolone Acetate Ophthalmic (1%)
14 Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis Completed NCT00406887 Phase 3 Difluprednate Ophthalmic Emulsion
15 Safety and Efficacy Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution to Treat Non-Infectious Anterior Segment Uveitis Completed NCT01505088 Phase 3 40 mg/mL Dexamethasone phosphate ophthalmic solution;Prednisolone Acetate (1%) Eyedrops;100 mM sodium citrate buffer solution;Placebo Eyedrops
16 Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe Uveitis Completed NCT00407056 Phase 3 Difluprednate Ophthalmic Emulsion
17 Herpetic Eye Disease Study (HEDS) II Completed NCT00000139 Phase 3 Acyclovir
18 Study of Difluprednate in the Treatment of Uveitis Completed NCT00501579 Phase 3 Difluprednate;Prednisolone Acetate
19 CLARITY Extension Study Completed NCT00641537 Phase 3 Cladribine;Placebo;Cladribine;Cladribine;Placebo
20 Suprachoroidal Injection of CLS-TA in Subjects Non-infectious Uveitis Completed NCT03097315 Phase 3
21 Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis Completed NCT02595398 Phase 3 4mg CLS-TA Suprachoriodal Injection;Sham Procedure
22 A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis Completed NCT02696785 Phase 3 Ixekizumab;Placebo;Adalimumab
23 SOLACE Trial - A Phase 3 Trial in Subjects With Non-infectious Anterior-uveitis. Recruiting NCT03131154 Phase 3 ADX-102 Ophthalmic Solution (0.5%);Vehicle of ADX-102 Ophthalmic Solution
24 Treatment Tapering in JIA With Inactive Disease Recruiting NCT02840175 Phase 3 etanercept;adalimumab;Abatacept;Tocilizumab
25 A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis Active, not recruiting NCT03129100 Phase 3 Ixekizumab;Placebo
26 Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of AS Active, not recruiting NCT02552212 Phase 3
27 A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis Active, not recruiting NCT02757352 Phase 3 Ixekizumab;Placebo
28 A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis Active, not recruiting NCT02696798 Phase 3 Ixekizumab;Placebo
29 Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes Not yet recruiting NCT03586284 Phase 2, Phase 3 Valganciclovir Hydrochloride;Ganciclovir Sodium;Placebo Oral Tablet;Topical placebo
30 Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis Not yet recruiting NCT03576898 Phase 2, Phase 3 Topical ganciclovir versus oral valganciclovir versus placebo
31 Preventing Extension of Oligoarticular Juvenile Idiopathic Arthritis JIA (Limit-JIA) Not yet recruiting NCT03841357 Phase 3 Abatacept Injection
32 A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Anterior Uveitis Terminated NCT00333996 Phase 2, Phase 3 Dexamethasone
33 Proof of Concept Study to Evaluate Safety and Efficacy of LME636 in the Treatment of Acute Anterior Uveitis Completed NCT02482129 Phase 2 LME636 60 mg/mL ophthalmic solution;Dexamethasone 0.1% ophthalmic solution;LME636 Vehicle
34 A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis Completed NCT02406209 Phase 2 NS2;Prednisolone acetate ophthalmic suspension (1%)
35 Safety and Efficacy Study of DSP-Visulex for the Treatment of Anterior Uveitis Completed NCT02309385 Phase 1, Phase 2 8% Dexamethasone Sodium Phosphate - Visulex;15% Dexamethasone Sodium Phosphate - Visulex;Prednisolone Acetate (1%) Eye Drops
36 Exploratory Study on Topical ESBA105 in Acute Anterior Uveitis Completed NCT00823173 Phase 2
37 Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis Completed NCT00405496 Phase 2 Difluprednate Ophthalmic Emulsion
38 Human Anti-Tac (Daclizumab) to Treat Juvenile Idiopathic Arthritis (JIA)-Associated Uveitis Completed NCT00130637 Phase 2 Daclizumab
39 Topical Interferon Gamma for Macular Edema Secondary to Uveitis Completed NCT01376362 Phase 1, Phase 2 Interferon Gamma-1b
40 Safety and Efficacy Study of Iontophoresis and Dexamethasone Phosphate to Treat Anterior Uveitis Completed NCT00694135 Phase 2 EGP-437 1.6 mA-min at 0.4 with EyeGate® II System;EGP-437 4.8 mA-min at 1.2 mA with EyeGate® II System;EGP-437 10.0 mA-min at 2.5 mA with EyeGate® II System;EGP-437 14.0 mA-min at 3.5 mA with EyeGate® II System
41 Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis Completed NCT02255032 Phase 2 4 mg CLS-TA;0.8 mg CLS-TA
42 Safety and Efficacy of AIN457 in Noninfectious Uveitis Completed NCT00685399 Phase 2 AIN457;AIN 457;AIN457
43 A Phase I/IIa Study for the Treatment of Uveitis With Iontophoresis Withdrawn NCT00499551 Phase 1, Phase 2
44 Subconjunctival Sirolimus for the Treatment of Autoimmune Active Anterior Uveiti Completed NCT00876434 Phase 1 Sirolimus
45 Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated Fibroblast Growth Factor (FGF) Pathway Signaling Completed NCT01868022 Phase 1 GSK3052230;paclitaxel;carboplatin;docetaxel;pemetrexed;cisplatin
46 Subconjunctival IVIg (Gamunex-C) Injection for Corneal Neovascularization and Inflammatory Conditions Withdrawn NCT02042027 Phase 1 Gamunex-C
47 Acute Anterior Uveitis: Psychic Burden and Pain Unknown status NCT01156285
48 Clinical Outcomes of Topical Ganciclovir Treatment in Cytomegalovirus Anterior Uveitis Unknown status NCT01486693
49 Variations in Retinal Nerve Fiber Layer Thickness During Uncomplicated Anterior and Intermediate Uveitis Unknown status NCT02879084
50 Quality of Life and Visual Function in Uveitis Patients Unknown status NCT00407316

Search NIH Clinical Center for Iridocyclitis

Inferred drug relations via UMLS 74 / NDF-RT 52 :


Cochrane evidence based reviews: iridocyclitis

Genetic Tests for Iridocyclitis

Anatomical Context for Iridocyclitis

MalaCards organs/tissues related to Iridocyclitis:

42
Eye, Retina, Endothelial, Thyroid, Testes, Skin, Liver

Publications for Iridocyclitis

Articles related to Iridocyclitis:

(show top 50) (show all 288)
# Title Authors Year
1
Intraocular Lymphoma Masquerading as Recurrent Iridocyclitis: Findings Based on in vivo Confocal Microscopy. ( 29099641 )
2018
2
Fever of unknown origin, bilateral sensorineural hearing loss with canal paresis and uveitis with iridocyclitis and episcleritis: a case of Cogan's syndrome. ( 29703835 )
2018
3
Fuchs heterochromic iridocyclitis-associated glaucoma: a retrospective comparison of primary Ahmed glaucoma valve implantation and trabeculectomy with mitomycin C. ( 30410728 )
2018
4
Moth-eaten appearance of the iris in Fuchs heterochromic iridocyclitis. ( 30447956 )
2018
5
Anti-dense Fine Speckled 70 Autoantibodies in Japanese Children with Dermatomyositis, Localized Scleroderma, and Idiopathic Arthritis with Iridocyclitis. ( 28461535 )
2017
6
Risk Factors for Glaucoma in a Cohort of Patients with Fuchs Heterochromic Iridocyclitis. ( 27494676 )
2017
7
The unusual association of inverse retinitis pigmentosa and Fuchs' heterochromic iridocyclitis. ( 28127443 )
2017
8
Leprosy Presenting with Iridocyclitis: A Diagnostic Dilemma. ( 29090057 )
2017
9
Niemann-Pick Disease Type C Associated with Fuchs Heterochromic Iridocyclitis. ( 29387679 )
2017
10
Phacoemulsification Versus Manual Small Incision Cataract Surgery in Patients With Fuchs Heterochromic Iridocyclitis. ( 26939115 )
2016
11
Zika virus-related hypertensive iridocyclitis. ( 26840174 )
2016
12
Syphilis iridocyclitis in a patient with type 1 diabetes. ( 27180731 )
2016
13
Fuchs' Heterochromic Iridocyclitis in an Italian Tertiary Referral Centre: Epidemiology, Clinical Features, and Prognosis. ( 27781126 )
2016
14
Recurrent iridocyclitis due to cotton fiber in anterior chamber. ( 28242892 )
2016
15
Polymorphisms in cytomegalovirus genotype in immunocompetent patients with corneal endotheliitis or iridocyclitis. ( 25963863 )
2015
16
Clinical, histopathological and immunohistochemical characterization of a novel equine ocular disorder: heterochromic iridocyclitis with secondary keratitis in adult horses. ( 25399915 )
2015
17
Acute granulomatous iridocyclitis in a child with tubulointerstitial nephritis and uveitis syndrome. ( 25861394 )
2015
18
Bilateral acute iris transillumination (BAIT) initially misdiagnosed as acute iridocyclitis. ( 25945534 )
2015
19
Analysis on the psychological characteristics of patients with acute iridocyclitis. ( 26086022 )
2015
20
Fuch's Heterochromic Iridocyclitis in Iran: Is the Disease Going to Fade Away? ( 26730326 )
2015
21
Hypertensive iridocyclitis associated with delayed onset biopsy proven Cytomegalovirus retinitis. ( 23548320 )
2014
22
Polymorphisms of TNFAIP3 gene in a Chinese Han population with fuchs heterochromic iridocyclitis. ( 23463983 )
2014
23
Implantation of iris-claw Artisan intraocular lens for aphakia in Fuchs' heterochromic iridocyclitis. ( 23571252 )
2014
24
Small-incision cataract surgery in patients with Fuch's heterochromic iridocyclitis. ( 25680261 )
2014
25
Herniation of the retina in the central macula in an adult after iridocyclitis. ( 26011975 )
2014
26
Associations of Fuchs heterochromic iridocyclitis in a South Indian patient population. ( 23514352 )
2013
27
Surgical management of secondary glaucoma in Fuchs' heterochromic iridocyclitis. ( 23519886 )
2013
28
Chikungunya virus iridocyclitis in Fuchs' heterochromic iridocyclitis. ( 22218256 )
2012
29
Frequency of iridocyclitis in patients with early psoriatic arthritis: a prospective, follow up study. ( 22898222 )
2012
30
Corneal astigmatism in unilateral Fuchs heterochromic iridocyclitis. ( 21595529 )
2011
31
Bilateral acute depigmentation of the iris first misdiagnosed as acute iridocyclitis. ( 21633847 )
2011
32
Fuchs heterochromic iridocyclitis and the rubella virus. ( 21897135 )
2011
33
Adenoma of the nonpigmented ciliary epithelium presenting with recurrent iridocyclitis: unique expression of glial fibrillary acidic protein. ( 21088853 )
2011
34
Fuchs' heterochromic iridocyclitis associated with ocular toxocariasis. ( 21331701 )
2011
35
Levocetirizine-induced iridocyclitis in a patient with allergic rhinitis. ( 20232781 )
2010
36
Chikungunya virus iridocyclitis in Fuchs' heterochromic iridocyclitis. ( 20952847 )
2010
37
The possible role of systemic azithromycin for idiopathic iridocyclitis. ( 19891670 )
2010
38
Confocal scan features of keratic precipitates in Fuchs heterochromic iridocyclitis. ( 19907293 )
2010
39
Rubella virus as a possible etiological agent of Fuchs heterochromic iridocyclitis. ( 20585798 )
2010
40
Sarcoidosis presenting with massive splenomegaly in a child with a history of iridocyclitis and sensorineural deafness. ( 20615071 )
2010
41
Expression Profile of Intravitreous Cytokines, Chemokines and Growth Factors in Patients with Fuchs Heterochromic Iridocyclitis. ( 20737053 )
2010
42
Klebsiella pneumoniae endophthalmitis secondary to liver abscess presenting as acute iridocyclitis. ( 19772282 )
2009
43
Presumed Fuchs heterochromic iridocyclitis and Posner-Schlossman syndrome: comparison of cytomegalovirus-positive and -negative eyes. ( 19463548 )
2009
44
Retinal thickening in iridocyclitis. ( 19477710 )
2009
45
Fuchs heterochromic iridocyclitis--syndrome, disease, or both? ( 19782794 )
2009
46
Idiopathic no more: clues to the pathogenesis of Fuchs heterochromic iridocyclitis and glaucomatocyclitic crisis. ( 18435976 )
2008
47
Presumed fuchs heterochromic iridocyclitis and Posner-Schlossman syndrome: comparison of cytomegalovirus-positive and negative eyes. ( 19027423 )
2008
48
Kinetics of aqueous flare, intraocular pressure and virus-DNA copies in a patient with cytomegalovirus iridocyclitis without retinitis. ( 17522780 )
2007
49
Epidemiologic relationship between fuchs heterochromic iridocyclitis and the United States rubella vaccination program. ( 17631266 )
2007
50
Rubella virus is associated with fuchs heterochromic iridocyclitis. ( 16387009 )
2006

Variations for Iridocyclitis

Expression for Iridocyclitis

Search GEO for disease gene expression data for Iridocyclitis.

Pathways for Iridocyclitis

GO Terms for Iridocyclitis

Cellular components related to Iridocyclitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cell surface GO:0009986 9.56 HLA-A HLA-B HLA-DPB1 TNFRSF10B
2 recycling endosome membrane GO:0055038 9.37 HLA-A HLA-B
3 phagocytic vesicle membrane GO:0030670 9.32 HLA-A HLA-B
4 MHC class I protein complex GO:0042612 9.16 HLA-A HLA-B
5 ER to Golgi transport vesicle membrane GO:0012507 9.13 HLA-A HLA-B HLA-DPB1
6 integral component of lumenal side of endoplasmic reticulum membrane GO:0071556 8.8 HLA-A HLA-B HLA-DPB1

Biological processes related to Iridocyclitis according to GeneCards Suite gene sharing:

(show all 11)
# Name GO ID Score Top Affiliating Genes
1 immune response GO:0006955 9.67 CYP11B1 HLA-A HLA-B HLA-DPB1
2 type I interferon signaling pathway GO:0060337 9.49 HLA-A HLA-B
3 negative regulation of extrinsic apoptotic signaling pathway via death domain receptors GO:1902042 9.48 TNFAIP3 TNFRSF10B
4 antigen processing and presentation of peptide antigen via MHC class I GO:0002474 9.46 HLA-A HLA-B
5 antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent GO:0002479 9.43 HLA-A HLA-B
6 positive regulation of T cell mediated cytotoxicity GO:0001916 9.4 HLA-A HLA-B
7 interferon-gamma-mediated signaling pathway GO:0060333 9.33 HLA-A HLA-B HLA-DPB1
8 antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent GO:0002480 9.32 HLA-A HLA-B
9 antigen processing and presentation of endogenous peptide antigen via MHC class Ib GO:0002476 9.26 HLA-A HLA-B
10 protection from natural killer cell mediated cytotoxicity GO:0042270 8.96 HLA-A HLA-B
11 antigen processing and presentation GO:0019882 8.8 HLA-A HLA-B HLA-DPB1

Molecular functions related to Iridocyclitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 peptide antigen binding GO:0042605 8.8 HLA-A HLA-B HLA-DPB1

Sources for Iridocyclitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....